COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,388 Articles (22,816 medRxiv, 8,572 bioRxiv)

Most recent first Previous |  Page 1547: Articles 15461-15470  | Next

Different approaches to quantify years of life lost from COVID-19
Ferenci, T.
10.1101/2021.05.13.21257193 — Posted: 2021-05-14
SARS-CoV-2 naïve and recovered individuals show qualitatively different antibody responses following mRNA vaccination
Tejedor Vaquero, S., de Campos-Mata, L., Ramada, J. M., Diaz, P., Navarro-Barriuso, J., Ribas-Llaurado, C., Rodrigo Melero, N., Carolis, C., Cerutti, A., Gimeno, R., Magri, G.
10.1101/2021.05.07.21256821 — Posted: 2021-05-14
Pooling of samples for SARS-CoV-2 detection using rapid antigen tests
Salcedo, N., Harmon, A., Herrera, B. B.
10.1101/2021.02.09.21250610 — Posted: 2021-05-13
Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection
Cervantes-Barragan, L., Vanderheiden, A., Royer, C. J., Davis-Gardner, M. E., Ralfs, P., Chirkova, T., Anderson, L. J., Grakoui, A., Suthar, M. S.
10.1101/2021.05.12.443948 — Posted: 2021-05-13
CV2CoV, an enhanced mRNA-based SARS-CoV-2 vaccine candidate, supports higher protein expression and improved immunogenicity in rats
Roth, N., Schoen, J., Hoffmann, D., Thran, M., Thess, A., Mueller, S. O., Petsch, B., Rauch, S.
10.1101/2021.05.13.443734 — Posted: 2021-05-13
Optimizing the spatio-temporal allocation of COVID-19 vaccines: Italy as a case study
Lemaitre, J. C., Pasetto, D., Zanon, M., Bertuzzo, E., Mari, L., Miccoli, S., Casagrandi, R., Gatto, M., Rinaldo, A.
10.1101/2021.05.06.21256732 — Posted: 2021-05-13
Pharmacogenomic and drug interaction risk associations with hospital length of stay among Medicare Advantage members with COVID-19
Ashcraft, K., Moretz, C., Schenning, C., Rojahn, S., Tanudtanud, K. V., Magoncia, G. O., Reyes, J., Marquez, B., Guo, Y., Tokar-Erdemir, E., Hall, T. O.
10.1101/2021.05.06.21256769 — Posted: 2021-05-13
COVID-19 wastewater based epidemiology: long-term monitoring of 10 WWTP in France reveals the importance of the sampling context
LAZUKA, A., Arnal, C., Soyeux, E., Sampson, M., Lepeuple, A.-S., Deleuze, Y., Pouradier Duteil, S., Lacroix, S.
10.1101/2021.05.06.21256751 — Posted: 2021-05-13
SARS-CoV-2 RNA and antibody detection in human milk from a prospective multicenter study in Spain
Bauerl, C., Randazzo, W., Sanchez, G., Selma-Royo, M., Garcia-Verdevio, E., Martinez-Rodriguez, L., Parra-Llorca, A., Lerin, C., Fumado, V., Crovetto, F., Crispi, F., Perez-Cano, F. J., Rodriguez, G., Ruiz-Redondo, G., Campoy, C., Martinez-Costa, C., Collado, M. C.
10.1101/2021.05.06.21256766 — Posted: 2021-05-13
Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY
The OpenSAFELY Collaborative, , Walker, A. J., MacKenna, B., Inglesby, P., Rentsch, C. T., Curtis, H. J., Morton, C. E., Morley, J., Mehrkar, A., Bacon, S. C., Hickman, G., Bates, C., Croker, R., Evans, D., Ward, T., Cockburn, J., Davy, S., Bhaskaran, K., Schultze, A., Williamson, E. J., Hulme, W. J., McDonald, H. I., Tomlinson, L., Mathur, R., Eggo, R. M., Wing, K., Wong, A. Y., Forbes, H., Tazare, J., Parry, J., Hester, F., Harper, S., O'Hanlon, S., Eavis, A., Jarvis, R., Avramov, D., Griffiths, P., Fowles, A., Parkes, N., Douglas, I. J., Evans, S. J., Smeeth, L., Goldacre, B.
10.1101/2021.05.06.21256755 — Posted: 2021-05-13 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).